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Abstract
Background: According to the literature, benign bile duct tumors are exceedingly uncommon. To the best of our
knowledge, we report the largest extrahepatic bile duct villous adenoma described in the literature.
Case presentation: We present a case of a 77-year-old Caucasian woman with obstructive jaundice.
Laboratory tests revealed that she had elevated bilirubin and liver enzyme levels. A computed tomographic
scan showed a homogeneous 5 × 3–cm mass obstructing the common bile duct. The results of brush
cytology were consistent with a bile duct villous papilloma. However, on the basis of the tumor’s radiological
features, a preliminary diagnosis of extrahepatic bile duct malignant tumor was made. After discussion among
the multidisciplinary team, a surgical resection of the bile duct tumor was performed. Histopathological
examination confirmed a villous adenoma. The patient’s postoperative course was uneventful.
Conclusions: In patients with bulky extrahepatic bile duct tumors, surgical resection alone may be safe and
curative.
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Background
An extrahepatic bile duct villous adenoma is an
exceedingly rare benign epithelial tumor [1, 2]. We
present a case of a patient with a bulky villous aden-
oma of the common bile duct that was diagnosed and
successfully treated at Vilnius University Hospital
Santariškių Klinikos in Lithuania.
Case presentation
A 77-year-old Caucasian woman was admitted to
Panevėžys regional hospital in Lithuania because of a
1-day history of skin and scleral jaundice and weak-
ness. Her medical history included a laparoscopic
cholecystectomy 15 years earlier for a gallbladder
stone.
A clinical examination revealed only skin and scleral
jaundice. The patient’s laboratory test results were as
follows: total bilirubin (TBIL) 338.59 U/L (normal <21
U/L), direct (conjugated) bilirubin (DBIL) 294 U/L
(normal <5.3), alkaline phosphatase (ALP) 720.1 U/L
(normal 40–129), alanine transaminase (ALT) 52.0 U/L
(≤35), aspartate transaminase (AST) 142.1 U/L (normal
≤35), γ-glutamyl transpeptidase (GGT) 353.0 U/L (nor-
mal 9–40), and carbohydrate antigen 19-9 157.09 U/ml
(normal 0–37). On the basis of ultrasound and com-
puted tomography (CT) findings, cancer in the head of
the pancreas with invasion to the common bile duct
(CBD) was suspected. To alleviate jaundice and to per-
form brush cytology, percutaneous transhepatic bile
duct drainage was performed. After this procedure, de-
creases in TBIL (187.92 U/L), DBIL (95.69 U/L), ALP
(276.1 U/L), ALT (37.2 U/L), AST (73.0 U/L), and GGT
(123.8 U/L) were noted.
A bile duct villous papilloma was suspected on the
basis of brush cytology. Despite the results of these in-
vestigations, a chance of malignancy remained. The pa-
tient was referred to the local tertiary treatment center
for further treatment. At the Vilnius University Hospital
Santariškių Klinikos, a multidisciplinary team reviewed a
CT scan of the patient. The scan showed the presence of
a CBD-obstructing, homogeneous, 5 × 3–cm mass
below the fusion of extrahepatic ducts without any
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evidence of tumor metastasis in a common bile duct
surrounding tissue, the liver, right and left intrahepatic
ducts, and the pancreas. The patient’s periportal lymph
nodes were of normal size. On the basis of the tumor’s
radiological features, a preoperative diagnosis of extrahe-
patic bile duct malignant tumor was made (T1N0M0,
type I, by Bismuth-Corlette classification) (Fig. 1).
The multidisciplinary team assessed the absence of
tumor invasion in surrounding tissues and decided to
perform a surgical resection of the tumor. However,
there remained a possibility to perform a more radical
operation, such as pancreaticoduodenectomy, if the can-
cer was observed to involve the distal part of the CBD.
A laparotomy was performed. The duodenum and the
head of the pancreas were mobilized by using the
Kocher maneuver. Importantly, no trace of tumor was
found in the proximal common hepatic duct (CHD) and
distal CBD parts. Only bile duct parts containing tumor
were resected. To perform a Roux-en-Y hepaticojeju-
nostomy, a small intestine loop was mobilized and di-
vided 50 cm from the superior duodenal fold. The distal
part was closed and anastomosed end to side to the
remaining 0.5-cm length of the CHD. Sixty centimeters
below this junction, an end-to-side jejunojejunal anasto-
mosis was formed.
Macroscopic evaluation of the specimen revealed that
the resected parts of the CBD and CHD consisted of di-
lated bile ducts with a papillary tumor protruding into
the lumen. The tumor’s size was 4.5 × 4 × 2.5 cm. The
resection margin was 2 cm from one side and 2.5 cm
from the other, and two investigated lymph nodes were
identified as tumor-free (Fig. 2).
Histologically, the tumor consisted of branching papil-
lary structures lined by tall columnar epithelium with
slight nuclear atypia and scant fibrous stroma (Fig. 3a, b).
Invasive growth was not detected. The adenoma was
tested for microsatellite instability using immunostaining
of MLH1, PMS2, MSH2, and MSH6 proteins. Positive nu-
clear immunostaining was observed in tumor cells
(Fig. 3c), which showed no evidence of microsatellite
instability.
The patient’s postoperative course was uneventful. Her
hospitalization period was 10 days. At two visits during
the 18-month follow-up period, she had no complica-
tions or recurrence.
Discussion
All types of extrahepatic bile duct benign tumors are
very rare compared with malignant tumors. They ac-
count for 0.1 % of biliary tract operations and 6 % of all
extrahepatic bile duct masses [3].
The World Health Organization classification divides
benign epithelial gallbladder and extrahepatic bile duct
tumors into tubular, papillary, and tubulopapillary aden-
omas; biliary cystadenoma; and papillomatosis (adeno-
matosis) [4]. Tubulovillous adenomas can occur at any
site of the gastrointestinal tract but are usually located
in the colon and rectum and less frequently in the small
bowel. They are extremely rarely found in the CBD [1].
The most common site for villous adenomas in the bil-
iary duct tree is the distal part of the CBD [2, 5]. Villous
adenomas in the CBD are histologically similar to those
in the ampullary region, gallbladder, or intestine. Several
studies have shown that a small proportion of adenomas
progress to carcinoma, and there are also general consid-
erations that benign tumors can have similar biological be-
havior, such as adenoma-to-carcinoma sequences in the
colon [4, 6, 7].
Although in general they are rare, benign extrahepatic
bile duct tumors occur with greater frequency in the
sixth decade of human life [7–9]. Adenomas of extrahe-
patic bile ducts are usually symptomatic and cause bil-
iary obstruction. Jaundice, intermittent pain, dyspepsia,
weight loss, nausea, vomiting, malaise, and fever are
Fig. 1 Computed tomographic scan shows the presence of common bile duct–obstructing homogeneous mass (arrows). a Coronal view.
b Axial view
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common presenting features of benign biliary tumors
[3]. Our patient presented with only obstructive jaun-
dice. These tumors rarely grow large enough to become
palpable, owing to their anatomical site. Their size
usually varies between 1 and 3 cm in diameter [4, 8].
Laboratory studies usually show elevation of blood bili-
rubin, alkaline phosphatase, and liver enzyme levels [8].
Ultrasound and CT show an intraductal tumor with dila-
tion of the CBD and the intrahepatic biliary tree [2, 3].
Differentiating a villous adenoma from a malignant
tumor preoperatively is complex. These tumors have
similar clinical presentations [10]. The possibility of in-
vasive carcinoma increases with tumor size and number
of lesions [1]. Sonograms, endoscopic ultrasound, CT,
and endoscopic retrograde or magnetic resonance cho-
langiopancreatographies differentiate these tumors with
limited success [1, 10]. In imaging-based studies, re-
searchers have found that only 60 % of patients with ex-
trahepatic bile duct adenomas have dilated biliary ducts
[3]. According to Stewart et al., brush cytology is a use-
ful technique for initial investigation in patients with
suspected pancreaticobiliary neoplasias [11].
Because of complex diagnostics, all previously de-
scribed factors are evaluated to determine a treatment
strategy. Surgical intervention might be appropriate in
patients with apparently localized disease, regardless of
the cause of the stricture. Patients might have a higher
risk of recurrence if they are treated by endoscopic re-
section alone [12, 13]. Radical resection should be ad-
vised if malignancy is suspected or the tumor size is
more than 2 cm [7, 13, 14]. Also, pancreaticoduodenect-
omy should be considered mandatory in cases involving
cancer of the distal CBD [7]. Local resection alone might
be curative for high-risk patients who are thought to
have benign tumors, such as our patient [14, 15]. Also, it
is believed that local resection with lymph node dissec-
tion of the hepatoduodenal ligament might be curative
in cases of malignancies in the midpart of the CBD [14],
but this requires further study.
Studies have shown that there are no complications
or recurrences after local resection of extrahepatic
bile duct adenoma; however, in all of the cases re-
ported in those studies, the follow-up period was less
than 1–2 years [8, 14].
Fig. 2 Surgical-pathological findings of a tumor inside the bile duct. a Intact bile duct. b Dissected bile duct
Fig. 3 Microscopic examination (hematoxylin and eosin–stained slides). a General view of the tumor shows villous pattern of growth (original
magnification, ×6). b Cytological details of the tumor cells: slight nuclear atypia with no invasive growth (original magnification, ×68). c Strong
nuclear reaction with MSH2 immunomarker (original magnification, ×98)
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Conclusions
Villous adenoma is a rare extrahepatic biliary tree benign
tumor. It is important to diagnose and resect it early be-
cause only surgery can rule out the malignancy. A tumor
can be found without malignancy even if its size reaches
3 cm or more. Therefore, surgical resection alone may
be safe and curative for bulky tumors.
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